Akers Biosciences, Inc. (AKER) - Medical Equipment - Deals and Alliances Profile

Date: October 18, 2016
Pages: 57
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AC7CDC2ABA2EN
Leaflet:

Download PDF Leaflet

Akers Biosciences, Inc. (AKER) - Medical Equipment - Deals and Alliances Profile
Summary

Akers Biosciences, Inc. (ABI) is a medical device company that develops, manufactures and supplies in vitro diagnostic technologies. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA Chlamydia, PIFA Dengue Fever, PIFA Malaria, PIFA Syphilis, PIFA Heparin, and breath ketone. ABI provides testing platform technologies that include MPC biosensor, particle immune-filtration assay, rapid enzymatic assay, minDNA, and synthetic macrocycle complex. The company also offers seraSTAT rapid blood cell separation, a sample preparation technology. It provides its products to healthcare facilities. ABI is headquartered in West Deptford, New Jersey, the US.

Akers Biosciences, Inc. (AKER) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Akers Biosciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deal Details
Asset Purchase
Akers Biosciences Acquires Technology Assets From Pulse Health
Partnerships
Akers Biosciences Enters into Distribution Agreement with Aero-Med
Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management
Akers Biosciences Enters into Distribution Agreement with Medline Industries
Akers Biosciences Enters into Distribution Agreement with Typenex
Equity Offering
Akers Biosciences Completes Public Offering Of Shares For US$15 Million
Akers Biosciences Completes Private Placement Of US$3.2 Million
Akers Biosciences, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Aug 11, 2016: Akers Biosciences Announces H1 and Q2 2016 Earnings
May 12, 2016: Akers Biosciences: Financial Results for the First Quarter 2016
May 12, 2016: Akers Biosciences Reports Earnings for Q1 2016
Mar 30, 2016: Akers Biosciences Reports Earnings for Fiscal Year 2015
Aug 18, 2015: Akers Biosciences Announces Q2 2015 Earnings
May 14, 2015: Akers Biosciences Announces Financial Results for First Quarter 2015
Mar 23, 2015: Akers Biosciences Reports Earnings for Fiscal Year 2014
Corporate Communications
Apr 29, 2016: Akers Board Rearrangement
Apr 25, 2016: Akers Biosciences: Board Rearrangement
Feb 29, 2016: Akers Biosciences Hires Leading Commercial Executives to Support Sales Growth
Nov 23, 2015: Akers Biosciences Appoints Medical Technology Specialist as CEO
Nov 12, 2015: Akers Biosciences Appoints Dr. Raza Bokhari as Non-executive Director
Jun 30, 2015: Akers Biosciences Appoints Former Congressman Rob Andrews to the Board
Jan 20, 2015: Akers Expands U.S. Sales Efforts with Key Leadership Additions
Legal and Regulatory
Aug 19, 2016: Akers Biosciences Announces Settlement of Dispute with ChubeWorkx
Feb 09, 2015: Akers Management System Certified to ISO 13485 (2003)
Product News
Mar 23, 2016: Akers Biosciences Allowed US Patent for Heparin/PF4 Antibody Detection
Mar 02, 2016: Akers Biosciences Announces $2.5M Order to Supply PIFA Heparin/PF4 Products to China
Nov 04, 2015: Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration
Apr 13, 2015: Akers Biosciences Further Expands International Distribution Of Flagship Rapid Test
Product Approvals
Nov 04, 2015: Akers Biosciences' Flagship Test for Heparin-Induced Thrombocytopenia Granted Approval by Chinese Food and Drug Administration
Other Significant Developments
Nov 13, 2015: Akers Biosciences Announces Q3 2015 Earnings
Apr 02, 2015: Akers Bio Signs Distribution Agreement With ADS for U.S. Govt.
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer 57

LIST OF TABLES

Akers Biosciences, Inc., Medical Equipment, Key Facts, 2015
Akers Biosciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Akers Biosciences, Inc., Deals By Market, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Akers Biosciences Acquires Technology Assets From Pulse Health
Akers Biosciences Enters into Distribution Agreement with Aero-Med
Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management
Akers Biosciences Enters into Distribution Agreement with Medline Industries
Akers Biosciences Enters into Distribution Agreement with Typenex
Akers Biosciences Completes Public Offering Of Shares For US$15 Million
Akers Biosciences Completes Private Placement Of US$3.2 Million
Akers Biosciences, Inc., Key Competitors
Akers Biosciences, Inc., Key Employees
Akers Biosciences, Inc., Subsidiaries 21

LIST OF FIGURES

Akers Biosciences, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Akers Biosciences, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Akers Biosciences, Inc. (AKER) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: